What are the core defects of Diabetes Mellitus type 2 (DM2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

The core defects of Type 2 Diabetes Mellitus (DM2) include insulin resistance, impaired insulin secretion, and increased hepatic glucose production, as stated in the most recent and highest quality study 1. These defects are characterized by the body's inability to properly respond to insulin, leading to high blood glucose levels. Insulin resistance occurs when muscle, fat, and liver cells don't respond properly to insulin, requiring the pancreas to produce more insulin to overcome this resistance. Over time, the pancreatic beta cells become unable to produce sufficient insulin to maintain normal blood glucose levels, leading to impaired insulin secretion. Some key points about the core defects of DM2 include:

  • Insulin resistance: muscle, fat, and liver cells don't respond properly to insulin, requiring the pancreas to produce more insulin to overcome this resistance 1.
  • Impaired insulin secretion: the pancreatic beta cells become unable to produce sufficient insulin to maintain normal blood glucose levels 1.
  • Increased hepatic glucose production: the liver inappropriately increases glucose production through gluconeogenesis, especially during fasting states, further contributing to hyperglycemia 1. These combined defects create a vicious cycle where hyperglycemia itself can worsen insulin resistance and further impair beta cell function, a phenomenon known as glucotoxicity. Genetic predisposition, obesity, physical inactivity, and aging all contribute to the development and progression of these core defects in DM2, as supported by the evidence from 1.

From the Research

Core Defects of DM2

The core defects of Type 2 Diabetes Mellitus (DM2) include:

  • Insulin resistance: a condition in which the body's cells do not respond effectively to insulin, leading to impaired glucose uptake in the muscles and increased glucose production in the liver 2, 3, 4
  • Impaired insulin secretion: a condition in which the pancreas does not produce enough insulin to meet the body's needs, leading to hyperglycemia 2, 3, 4

Pathophysiological Abnormalities

In addition to insulin resistance and impaired insulin secretion, at least six other pathophysiological abnormalities contribute to the dysregulation of glucose metabolism in DM2, including:

  • Environmental factors such as obesity, an unhealthy diet, and physical inactivity 2, 3, 4
  • Genetic factors that contribute to the development of insulin resistance and impaired insulin secretion 2, 3, 4
  • Mitochondrial dysfunction, impaired regulation of the enteroinsular axis, and endoplasmic reticulum stress 4
  • Adipose tissue dysfunction, which secretes adipocytokines with diverse central and peripheral metabolic effects 4

Clinical Features

The clinical features of insulin resistance and beta-cell dysfunction in DM2 include:

  • Reduced insulin-stimulated glucose uptake, reduced insulin-suppression of endogenous glucose production, and reduced antilipolysis 3
  • Decreased insulin-induced vasodilation, dyslipidemia, and platelet hyperaggregability 3
  • Hyperglycemia, both post-absorptively and postprandially 3

Related Questions

How should the medication regimen be adjusted for a 51-year-old woman with type 2 diabetes on metformin 500 mg twice daily, glimepiride 1 mg daily, and linagliptin 2.5 mg daily, who has elevated HbA1c (~8 %), hyperglycemia (random glucose ~263 mg/dL), mildly elevated cholesterol and triglycerides, mildly elevated TSH, normal blood pressure, heart rate, oxygen saturation, and BMI, and feels well?
Is there any rationale or indication for using a glucagon‑like peptide‑1 receptor agonist together with a dipeptidyl peptidase‑4 inhibitor in a patient with type 2 diabetes?
What is the immediate next step for a 70-year-old patient, a chronic smoker, with a history of type 2 diabetes, presenting with transient twisting of the right hand index and little finger and right foot last three toes?
What is the safety and efficacy of Ashwagandha (Withania somnifera) for patients with diabetes mellitus?
What is the appropriate next-step management for a 56-year-old male with type 2 diabetes mellitus who is taking metformin 1000 mg twice daily and glipizide 5 mg daily, with a hemoglobin A1c of 9.2%?
What is the normal testosterone level in a 75-year-old (seventy-five years old) male?
What are the causes of olfactory hallucinations?
What is the frequency of neurological checks for vasogenic cerebral edema?
What topical corticosteroid (steroid) cream is recommended to apply along the scalp line?
What is the recommended dose of Nortriptyline (a tricyclic antidepressant) for pain management?
Is Salonpas (methyl salicylate) patch safe during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.